Enavogliflozin

DB18970InvestigationalSmall molecule

Enavogliflozin is under investigation in clinical trial NCT06399835 (Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis).

Chemical structure of Enavogliflozin
Mechanism
Curator reviewed
Formula / weight
C24H27ClO6 · 446.92 g/mol (avg)
Also known as
(1s)-1,5-anhydro-1-c-(7-chloro-6-((4-cyclopropylphenyl)methyl)-2,3-dihydro-4-benzofuranyl)-d-glucitol · D-glucitol, 1,5-anhydro-1-c-(7-chloro-6-((4-cyclopropylphenyl)methyl)-2,3-dihydro-4-benzofuranyl)-, (1s)-
Code names
DWP-16001 · ODP-9401

Resolves to

Compound
UNIIZ5MR2Y1IJJCAS1415472-28-4ChEMBLCHEMBL3703921
Clinical / RWD
ATCA10BK09
Structure
InChIKeyKORCWPOBTZTAFI-YVTYUBGGSA-NSMILES[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC(CC2=CC=C(C=C2)C2CC2)=C(Cl)C2=C1CCO2
Targets
P31639SLC5A2

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
26Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
1ATC codeIncluding every combination product, plus 13 drug categories
Sign in
11+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Enavogliflozin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In